Endocrinology, Vol 129, 1481-1488, Copyright © 1991 by Endocrine Society

ARTICLES

Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors

V Papadopoulos, A Berkovich, KE Krueger, E Costa and A Guidotti
Department of Anatomy and Cell Biology, Georgetown University School of Medicine, Washington, D.C. 20007.

A recognition site for benzodiazepines structurally different from that linked to various gamma-aminobutyric acid A (GABAA) receptor subtypes is located on the outer mitochondrial membranes of steroidogenic cells. This protein has been signified to be important in the regulation of steroid biosynthesis. Because of its location it is designated herein as the mitochondrial benzodiazepine receptor (MBR). A putative endogenous ligand for MBR is the peptide diazepam binding inhibitor (DBI), previously shown to displace drugs from MBR and to be expressed and stored in steroidogenic cells rich in MBR. The two model systems used to study steroidogenic regulation by DBI were the Y-1 adrenocortical and MA-10 Leydig cell lines previously shown to be applicable in studies of mitochondrial steroidogenesis. Both cell lines contain DBI as well as DBI processing products, including the DBI fragments that on reverse phase HPLC coelute with the naturally occurring triakontatetraneuropeptide [TTN; DBI-(17-50)] and octadecaneuropeptide [DBI-(33-50)]. When DBI purified from rat brain was added to mitochondria prepared from Y-1 and MA-10 cell lines, it increased the rates of pregnenolone formation in a dose-related manner. In both cell lines, maximal stimulation (3-fold) of mitochondrial steroidogenesis was obtained with 0.33 microM DBI, with an EC50 of approximately 0.1 microM. However, DBI concentrations higher than 1 microM caused a smaller increase in pregnenolone formation. Flunitrazepam, a benzodiazepine that binds with high nanomolar affinity to MBR, was recently shown to act as an antagonist of ACTH and LH/hCG- induced steroidogenesis and was found in the present studies to inhibit DBI-stimulated mitochondrial steroidogenesis. During the incubation with mitochondria, DBI was partially processed to different peptide fragments, including octadecaneuropeptide and TTN. To determine whether DBI processing products influence mitochondrial steroid biosynthesis, several DBI fragments and other peptides structurally unrelated to DBI were tested. Among these, only TTN stimulated mitochondrial steroid synthesis in a dose-dependent manner similar to DBI.

This article has been cited by other articles:

				J. Liu, M. B. Rone, and V. Papadopoulos Protein-Protein Interactions Mediate Mitochondrial Cholesterol Transport and Steroid Biosynthesis J. Biol. Chem., December 15, 2006; 281(50): 38879 - 38893. [Abstract] [Full Text] [PDF]

				C. Duparc, H. Lefebvre, M.-C. Tonon, H. Vaudry, and J.-M. Kuhn Characterization of Endozepines in the Human Testicular Tissue: Effect of Triakontatetraneuropeptide on Testosterone Secretion J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5521 - 5528. [Abstract] [Full Text] [PDF]

				O. MASMOUDI, P. GANDOLFO, J. LEPRINCE, D. VAUDRY, A. FOURNIER, C. PATTE-MENSAH, H. VAUDRY, and M.-C. TONON Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates endozepine release from cultured rat astrocytes via a PKA-dependent mechanism FASEB J, January 1, 2003; 17(1): 17 - 27. [Abstract] [Full Text] [PDF]

				M. Gazouli, Z. Han, and V. Papadopoulos Identification of a Peptide Antagonist to the Peripheral-Type Benzodiazepine Receptor That Inhibits Hormone-Stimulated Leydig Cell Steroid Formation J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 627 - 632. [Abstract] [Full Text] [PDF]

				W. Xia, S. Spector, L. Hardy, S. Zhao, A. Saluk, L. Alemane, and N. L. Spector Tumor selective G2/M cell cycle arrest and apoptosis of epithelial and hematological malignancies by BBL22, a benzazepine PNAS, June 20, 2000; 97(13): 7494 - 7499. [Abstract] [Full Text] [PDF]

				O. Lesouhaitier, M. K. Kodjo, F. Cartier, V. Contesse, L. Yon, C. Delarue, and H. Vaudry The Effect of the Endozepine Triakontatetraneuropeptide on Corticosteroid Secretion by the Frog Adrenal Gland Is Mediated by Activation of Adenylyl Cyclase and Calcium Influx through T-Type Calcium Channels Endocrinology, January 1, 2000; 141(1): 197 - 207. [Abstract] [Full Text] [PDF]

				M. Gavish, I. Bachman, R. Shoukrun, Y. Katz, L. Veenman, G. Weisinger, and A. Weizman Enigma of the Peripheral Benzodiazepine Receptor Pharmacol. Rev., December 1, 1999; 51(4): 629 - 650. [Abstract] [Full Text] [PDF]

				M. Hardwick, D. Fertikh, M. Culty, H. Li, B. Vidic, and V. Papadopoulos Peripheral-Type Benzodiazepine Receptor (PBR) in Human Breast Cancer: Correlation of Breast Cancer Cell Aggressive Phenotype with PBR Expression, Nuclear Localization, and PBR-mediated Cell Proliferation and Nuclear Transport of Cholesterol Cancer Res., February 1, 1999; 59(4): 831 - 842. [Abstract] [Full Text] [PDF]

				H. Li and V. Papadopoulos Peripheral-Type Benzodiazepine Receptor Function in Cholesterol Transport. Identification of a Putative Cholesterol Recognition/Interaction Amino Acid Sequence and Consensus Pattern Endocrinology, December 1, 1998; 139(12): 4991 - 4997. [Abstract] [Full Text] [PDF]

				R Avallone, M L Zeneroli, I Venturini, L Corsi, P Schreier, M Kleinschnitz, C Ferrarese, F Farina, C Baraldi, N Pecora, et al. Endogenous benzodiazepine-like compounds and diazepam binding inhibitor in serum of patients with liver cirrhosis with and without overt encephalopathy Gut, June 1, 1998; 42(6): 861 - 867. [Abstract] [Full Text] [PDF]

				V. Papadopoulos, H. Amri, H. Li, N. Boujrad, B. Vidic, and M. Garnier Targeted Disruption of the Peripheral-type Benzodiazepine Receptor Gene Inhibits Steroidogenesis in the R2C Leydig Tumor Cell Line J. Biol. Chem., December 19, 1997; 272(51): 32129 - 32135. [Abstract] [Full Text] [PDF]